Dummy Project
DIAB-220
Main lifecycle case for ordinary trials becoming complicated.
Project Story
What readers should notice
DIAB-220 is written as a case a working PM can recognize, not as a sterile protocol summary. The project sits in Metabolic as a Randomized controlled study, but the real teaching point is this: ordinary Phase III work becomes complicated through fasting visits, rescue medication, eCOA burden, supply configuration, site contracts, and database-lock pressure. When readers compare DIAB-220 with their own project, they should look for the same pressure points: what the protocol assumes, what sites can actually do, what vendors must prove, what data must remain credible, what safety or ethics concern could change the plan, and what Daniel Liang's team would ask before accepting a green dashboard as truth.
Lifecycle Coverage
Book Mentions
How to read this case
Look for the moment when ordinary project language stops being enough: a date slips, an assumption fails, a vendor signal loses meaning, or a clinical concern changes the work. Then follow the chapter links, toolkit examples, glossary terms, and packet artifacts to compare this fictional pressure pattern with a real project you manage.